The problem with nutritionally enhanced plants

Journal of Medicinal Food

Volumn 11, Issue 4, 2008, Pages 601-605

  Schubert, David R ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Bioactive compounds; Cancer; Diet; Natural food; Nutrigenomics; Nutrition

Indexed keywords

ALPHA TOCOPHEROL; AMINO ACID; BETA CAROTENE; GLUCOSE; LYCOPENE; OMEGA 3 FATTY ACID; RETINOID; TRYPTOPHAN; VITAMIN;

AMINO ACID METABOLISM; BIOENGINEERING; BIOLOGICAL ACTIVITY; CARBOHYDRATE METABOLISM; CORN; DEPRESSION; DIET SUPPLEMENTATION; DNA MODIFICATION; EOSINOPHILIA MYALGIA SYNDROME; FERMENTATION; FOOD SAFETY; GLUCOSE METABOLISM; HEALTH CARE POLICY; INSOMNIA; MAIZE; NERVOUS SYSTEM DEVELOPMENT; NUTRITIONAL SCIENCE; PLANT; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RICE; UNITED STATES; VISION; WINE; YEAST;

ANTIOXIDANTS; BETA CAROTENE; CONSUMER PRODUCT SAFETY; CROPS, AGRICULTURAL; DIETARY SUPPLEMENTS; FOOD SUPPLY; FOOD, GENETICALLY MODIFIED; HUMANS; ORGANISMS, GENETICALLY MODIFIED; ORYZA SATIVA; PLANTS, GENETICALLY MODIFIED; TRANSFECTION; TRYPTOPHAN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; YEASTS;

EID: 57349182776     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.0094     Document Type: Review

References (58)

1. Ye X, Al-Babili S, Kloti A, et al.: Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science 2000;287:303-305.
2. Cahoon EB, Hall SE, Ripp KG, et al.: Metabolic redesign of vitamin E biosynthesis in plants for tocotrienol production and increased antioxidant content. Nat Biotechnol 2003;21:1082-1087.
3. Van Eenennaam AL, Lincoln K, Durrett TP, et al.: Engineering vitamin E content: from Arabidopsis mutant to soy oil. Plant Cell 2003;15:3007-3019.
4. Kinney AJ: Metabolic engineering in plants for human health and nutrition. Curr Opin Biotechnol 2006;17:130-138.
5. Schubert D: A different perspective on GM food. Nat Biotechnol 2002;20:969.
6. Prescott VE, Campbell PM, Moore A, et al.: Transgenic expression of bean alpha-amylase inhibitor in peas results in altered structure and immunogenicity. J Agric Food Chem 2005;53:9023-9030.
7. van Ree R, Cabanes-Macheteau M, Akkerdaas J, et al.: Beta(1,2)-xylose and alpha(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens. J Biol Chem 2000;275:11451-11458.
8. FDA POLICY: Statement of policy: foods derived from new plant varieties; notice. Federal Register 1992;57(104):22983-23005.
9. U.S. Food and Drug Administration: List of completed consultations on bioengineered foods. http://www.cfsan.fda.gov/~lrd/consulpr.html (accessed November 2007).
10. Schwab W: Metabolome diversity: too few genes, too many metabolites? Phytochemistry 2003;62:837-849.
11. Krawinkel MB: What we know and don't know about Golden Rice. Nat Biotechnol 2007;25:623; author reply 624.
12. Enserink M: Tough lessons from golden rice. Science 2008;320:468-471.
13. Adams J, Holson RR: The neurobehavioral teratology of vitamin A analogs. In: Handbook of Developmental Neurotoxicology (Slikker W, Chang LW, eds.). Academic Press, San Diego, CA, 1998, pp. 631-642.
14. th ed. (Hardman JG, Limbird LE, Gilman AG, eds.). McGraw Hill, New York, 2001, pp. 1773-1791.
15. Teelmann K: Retinoids: toxicology and teratogenicity to date. Pharmacol Ther 1989;40:29-43.
16. th edition (Hardman JG, Limbird LE, Gilman AG, eds.). McGraw Hill, New York, 2001, pp. 1795-1818.
17. Wilson A, Latham J, Steinbrecher R: Genome Scrambling - Myth or Reality? Transformation - Induced Mutations in Transgenic Crop Plants. EcoNexus, Brighton, UK, 2004, p. 35.
18. Zubieta C, Ross JR, Koscheski P, et al.: Structural basis for substrate recognition in the0 salicylic acid carboxyl methyltransferase family. Plant Cell 2003;15:1704-1716.
19. Johnson ET, Ryu S, Yi H, et al.: Alteration of a single amino acid changes the substrate specificity of dihydroflavonol 4-reductase. Plant J 2001;25:325-333.
20. Poerschmanna J, Gathmannb A, Augustinc J, Langera U, Goreckid T: Molecular composition of leaves and stems of genetically modified Bt and near-isogenic non-Bt maize - characterization of lignin patterns. J Environ Qual 2005;34:1508-1518.
21. Diamond JM: Guns, Germs, and Steel: The Fates of Human Societies. W.W. Norton, New York, 1997.
22. Mayeno AN, Gleich GJ: Eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale. Trends Biotechnol 1994;12:346-352.
23. Hill RH, Caudill SP, Philen RM, et al.: Contaminants in L-tryptophan associated with eosinophilia myalgia syndrome. Arch Environ Contam Toxicol 1993;25:134-142.
24. Munn DH, Zhou M, Attwood JT, et al.: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998;281:1191-1193.
25. Platten M, Ho PP, Youssef S, et al.: Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 2005;310:850-855.
26. Romani L, Fallarino F, De Luca A, et al.: Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008;451:211-215.
27. Huang S, Frizzi A, Florida CA, Kruger DE, Luethy MH: High lysine and high tryptophan transgenic maize resulting from the reduction of both 19- and 22-kD alpha-zeins. Plant Mol Biol 2006;61:525-535.
28. Inose T, Murata K: Enhanced accumulation of toxic compound in yeast cells having high glycolytic activity: a case study on the safety of genetically engineered yeast. Int J Food Sci Technol 1995;30:141-146.
29. Kurien BT, Hensley K, Bachmann M, Scofield RH: Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med 2006;41:549-556.
30. BioSpringer: ML01: The first available malolactic wine yeast. http://www.lesaffreyeastcorp.com/wineyeast/ML01%20KH%206-13-05.pdf OE828.11/04 (accessed November 11, 2004).
31. DellaPenna D, Pogson BJ: Vitamin synthesis in plants: tocopherols and carotenoids. Annu Rev Plant Biol 2006;57:711-738.
32. Verpoorte R: Plant secondary metabolism. In: Metabolic Engineering of Plant Secondary Metabolism (Verpoorte R, Alfermann AW, eds.). Kluwer Academic Publishers, Dordrecht, The Netherlands, 2000, pp. 1-29.
33. Roessner U, Luedemann A, Brust D, et al.: Metabolic profiling allows comprehensive phenotyping of genetically or environmentally modified plant systems. Plant Cell 2001;13:11-29.
34. Romer S, Lubeck J, Kauder F, et al.: Genetic engineering of a zeaxanthin-rich potato by antisense inactivation and co-suppression of carotenoid epoxidation. Metab Eng 2002;4:263-272.
35. National Research Council, National Academy of Science: The Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects. National Academies Press, Washington, DC, 2004. http://books.nap.edu/catalog/10977.html (accessed July 28, 2004).
36. Sommer A: New imperatives for an old vitamin (A). J Nutr 1989;119:96-100.
37. Khush G: Productivity improvements in rice. Nutr Rev 2003;61(Suppl):S114-S116.
38. McCaffery PJ, Adams J, Maden M, Rosa-Molinar E: Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur J Neurosci 2003;18:457-472.
39. Allen JG, Bloxham DP: The pharmacology and pharmacokinetics of the retinoids. Pharmacol Ther 1989;40:1-27.
40. Donahue SP: Recurrence of idiopathic intracranial hypertension after weight loss: the carrot craver. Am J Ophthalmol 2000;130:850-851.
41. Auldridge ME, McCarty DR, Klee HJ: Plant carotenoid cleavage oxygenases and their apocarotenoid products. Curr Opin Plant Biol 2006;9:315-321.
42. Moise AR, von Lintig J, Palczewski K: Related enzymes solve evolutionarily recurrent problems in the metabolism of carotenoids. Trends Plant Sci 2005;10:178-186.
43. Dawson MI, Zhang XK: Discovery and design of retinoic acid receptor and retinoid X receptor class- and subtype-selective synthetic analogs of all-trans-retinoic acid and 9-cis-retinoic acid. Curr Med Chem 2002;9:623-637.
44. Grotewold E: Plant metabolic diversity: a regulatory perspective. Trends Plant Sci 2005;10:57-62.
45. Cole GM, Teter B, Frautschy SA: Neuroprotective effects of curcumin. Adv Exp Med Biol 2007;595:197-212.
46. Roland I, De Leval X, Evrard B, et al.: Modulation of the arachidonic cascade with omega3 fatty acids or analogues: potential therapeutic benefits. Mini Rev Med Chem 2004;4:659-668.
47. Cuddihy SL, Ali SS, Musiek ES, et al.: Prolonged alpha-tocopherol deficiency decreases oxidative stress and unmasks alpha-tocopherol-dependent regulation of mitochondrial function in brain. J Biol Chem 2008;283:6915-6924.
48. Lonn E, Bosch J, Yusuf S, et al.: Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005;293:1338-1347.
49. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-1035.
50. McHughen A, Smyth S: US regulatory system for genetically modified [genetically modified organism (GMO), rDNA or transgenic] crop cultivars. Plant Biotechnol J 2008;6:2-12.
51. Bradford KJ, Van Deynze A, Gutterson N, Parrott W, Strauss SH: Regulating transgenic crops sensibly: lessons from plant breeding, biotechnology and genomics. Nat Biotechnol 2005;23:439-444.
52. Miller HI, Conko C, Kershen DL: Why spurning food biotech has become a liability. Nat Biotechnol 2006;24:1075-1077.
53. Schubert D: Two views of the emperor's new clones. Nat Biotechnol 2007;25:282-283.
54. National Toxicology Program: Multigenerational Reproductive Toxicology Study of Ethinyl Estradiol (CAS No. 57-63-6) in Sprague-Dawley Rats (Feed Studies). National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC, 2007.
55. Pusztai A, Bardocz S: GMO in animal nutrition: potential benefits and risks. In: Biology of Nutrition in Growing Animals (Mosenthin R, Zentek J, Zebrowska T, eds.). Elsevier, Amsterdam, The Netherlands, 2006, pp. 513-540.
56. Freese W, Schubert D: Safety testing of genetically engineered food. Biotechnol Genet Eng Rev 2004;21:299-325.
57. Domingo JL: Toxicity studies of genetically modified plants: a review of the published literature. Crit Rev Food Sci Nutr 2007;47:721-733.
58. Mandel GN: Gaps, inexperience, inconsistencies, and overlaps: crisis in the regulation of genetically modified plants and animals. In: William & Mary Law Review, Vol. 45. William & Mary Marshall-Wythe School of Law, Williamsburg, VA, 2004, pp. 2167-2259.